Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nektar Therapeutics - Common Stock
(NQ:
NKTR
)
71.33
+0.33 (+0.46%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,271,381
Open
70.48
Bid (Size)
71.50 (1,500)
Ask (Size)
73.00 (1,900)
Prev. Close
71.00
Today's Range
67.70 - 73.37
52wk Range
6.480 - 73.37
Shares Outstanding
183,801,441
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Nasdaq, S&P 500 Futures Rise, Markets Await Jobless Claims: Why NVDA, META, NKTR, NVCR, AMAT, ASTS Are On Traders' Radar Today
↗
February 12, 2026
Via
Stocktwits
Topics
Stocks
NKTR Stock Skyrockets: Wall Street Sees Up To 200% Upside As Skin Trial Crushes Even Bull-Case Forecasts
↗
February 11, 2026
The company reported that complete skin clearance rates increased twofold to fivefold during the maintenance phase of the trial.
Via
Stocktwits
Performance
YTD
+64.3%
+64.3%
1 Month
+101.7%
+101.7%
3 Month
+19.7%
+19.7%
6 Month
+160.0%
+160.0%
1 Year
+384.0%
+384.0%
More News
Read More
Top stock movements in today's session.
↗
February 10, 2026
Via
Chartmill
Here are the top movers in Tuesday's session.
↗
February 10, 2026
Via
Chartmill
These stocks are gapping in today's session
↗
February 10, 2026
Via
Chartmill
Earnings Scheduled For November 6, 2025
↗
November 06, 2025
Via
Benzinga
Top movers in Tuesday's pre-market session
↗
February 10, 2026
Via
Chartmill
NKTR Stock Soars After Nektar Reports Positive Atopic Dermatitis Trial Results
↗
February 10, 2026
Via
Stocktwits
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
January 20, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
January 13, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
January 06, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Ignore Nektar Therapeutics Stock in 2026 and Load Up on This One Instead
↗
January 05, 2026
Via
The Motley Fool
Topics
Bankruptcy
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
December 30, 2025
From
Pomerantz LLP
Via
GlobeNewswire
This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table
↗
December 28, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away
↗
December 28, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know.
↗
November 20, 2025
Via
The Motley Fool
Nektar Therapeutics (NASDAQ:NKTR) Q3 2025 Earnings Top Estimates, Sending Shares Higher
↗
November 06, 2025
Via
Chartmill
This Stock Is Up By 285% This Year But Could Still Jump By 53%, According to Wall Street
↗
October 13, 2025
Via
The Motley Fool
Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September
↗
October 05, 2025
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
↗
October 03, 2025
Via
Benzinga
These 2 Healthcare Stocks Are Up Over 100% in a Month. Can They Keep Climbing?
↗
September 21, 2025
Via
The Motley Fool
Why Nektar Therapeutics Stock Zoomed More Than 15% Higher Today
↗
September 18, 2025
Via
The Motley Fool
Why Is Nektar Therapeutics Stock Trading Lower On Thursday?
↗
September 18, 2025
Via
Benzinga
Why Nektar Therapeutics Rippled Higher This Week
↗
September 05, 2025
Via
The Motley Fool
Topics
Intellectual Property
What's Going On With Nektar Therapeutics Stock On Thursday?
↗
September 04, 2025
Via
Benzinga
Frequently Asked Questions
Is Nektar Therapeutics - Common Stock publicly traded?
Yes, Nektar Therapeutics - Common Stock is publicly traded.
What exchange does Nektar Therapeutics - Common Stock trade on?
Nektar Therapeutics - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nektar Therapeutics - Common Stock?
The ticker symbol for Nektar Therapeutics - Common Stock is NKTR on the Nasdaq Stock Market
What is the current price of Nektar Therapeutics - Common Stock?
The current price of Nektar Therapeutics - Common Stock is 71.33
When was Nektar Therapeutics - Common Stock last traded?
The last trade of Nektar Therapeutics - Common Stock was at 02/13/26 04:00 PM ET
What is the market capitalization of Nektar Therapeutics - Common Stock?
The market capitalization of Nektar Therapeutics - Common Stock is 13.11B
How many shares of Nektar Therapeutics - Common Stock are outstanding?
Nektar Therapeutics - Common Stock has 13B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
